Tactile Systems Technology Inc
NASDAQ:TCMD
Tactile Systems Technology Inc
Total Equity
Tactile Systems Technology Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
Total Equity
$216.6m
|
CAGR 3-Years
19%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Equity
$25.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
17%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$20.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$20.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$47.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$16.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
See Also
What is Tactile Systems Technology Inc's Total Equity?
Total Equity
216.6m
USD
Based on the financial report for Dec 31, 2024, Tactile Systems Technology Inc's Total Equity amounts to 216.6m USD.
What is Tactile Systems Technology Inc's Total Equity growth rate?
Total Equity CAGR 5Y
14%
Over the last year, the Total Equity growth was 12%. The average annual Total Equity growth rates for Tactile Systems Technology Inc have been 19% over the past three years , 14% over the past five years .
You don't have any saved screeners yet